Stay updated on VRDN 001 Safety and Efficacy in TED Clinical Trial
Sign up to get notified when there's something new on the VRDN 001 Safety and Efficacy in TED Clinical Trial page.

Latest updates to the VRDN 001 Safety and Efficacy in TED Clinical Trial page
- Check2 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study content with a minimal error screen and navigation, indicating the page is inaccessible.SummaryDifference0.5%

- Check9 days agoChange DetectedA 403 Forbidden error page is now shown for the study record, replacing the usual content with an access-denied message. This indicates restricted access to the page rather than an update to study information.SummaryDifference18%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6, signaling a minor administrative update to the study record and its documentation. This change does not modify the substantive study details such as endpoints, eligibility criteria, or results.SummaryDifference0.0%

- Check44 days agoChange DetectedResults have been posted for the THRIVE study (NCT05176639), with a new 'Results Posted' entry dated 2026-08-13. The page now includes associated study documents describing veligrotug efficacy and safety outcomes.SummaryDifference3%

- Check51 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a new version of the page/document. This is a metadata/versioning change rather than a user-facing content update.SummaryDifference0.0%

- Check66 days agoChange DetectedThe study record now shows Results Submitted, replacing the previous No Results Posted, and the page revision updated from v3.6.3 to v3.6.4.SummaryDifference0.1%

Stay in the know with updates to VRDN 001 Safety and Efficacy in TED Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VRDN 001 Safety and Efficacy in TED Clinical Trial page.